The present invention relates to novel synthetic Neisseria meningitidis Serogroup A (hereinafter MenA) capsular polysaccharide repeating unit oligomer and a process for synthesizing said synthetic MenA capsular polysaccharide repeating unit oligomer. More specifically, the present invention relates to the chemical synthesis of the tetramer of MenA capsular polysaccharide repeating unit capable of being used as a candidate in the development of semisynthetic or fully synthetic conjugate vaccines as monovalent or as a part of combination vaccines against Meningococcal serogroup A bacterial infection.
本发明涉及新型合成的A群脑膜炎球菌(以下简称MenA)胶囊
多糖重复单元寡聚体,以及合成该合成MenA胶囊
多糖重复单元寡聚体的方法。更具体地,本发明涉及MenA胶囊
多糖重复单元四聚体的
化学合成,可用作开发半合成或全合成结合疫苗的候选物,作为单价疫苗或作为结合疫苗中针对A群脑膜炎球菌感染的组合疫苗的一部分。